Christelle did not receive the letter from the National Drug Safety Agency (ANSM) sent in September to 1.6 million women on a deogestrel-based contraceptive pill, which would cause one case of meningioma out of 17,000 women exposed over five years. The quadrennial took this pill, 26 years old, and she just learned that she had a brain tumor.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Christelle did not receive the letter from the National Drug Safety Agency (ANSM) sent in September to 1.6 million women on a deogestrel-based contraceptive pill, which would cause one case of meningioma out of 17,000 women exposed over five years. The quadrennial took this pill, 26 years old, and she just learned that she had a brain tumor.